Basic Treatment Planning

IMRT in breast cancer: data accumulating

Phase III Randomised Trial WBI vs IMRT 1145 pts End-point: late toxicity Results

– IMRT – less telangiectasia – No impact on breast shape

Not standard

Barnett et al. IJROBP 2012